Atrial cells have shorter action potential durations, so class Ib drugs don't work as well at therapeutic levels (IIRC, I think Lilly mentioned something like there's less time for the drug to bind and block the Na+ channel due to the shorter APD).
That's why class Ib drugs aren't effective for treating SVTs. Hope that helps.